Latest epilepsy Stories
- Major milestone for brivaracetam is latest step towards UCB goal of extending treatment choices for adult epilepsy patients with uncontrolled partial-onset seizures BRUSSELS, Jan.
RnRMarketResearch.com adds "Status Epilepticus - Pipeline Review, H2 2014" to its store. This report provides an overview of the Status Epilepticus's therapeutic pipeline. DALLAS, Jan.
The Northeast Regional Epilepsy Group is proud to announce that Dr. Lorraine Lazar is joining the NEREG pediatric epilepsy program starting in January of 2015.
LONDON, Jan. 7, 2015 /PRNewswire/ -- About Epilepsy TherapeuticsEpilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and life-threatening symptoms.
Treatment of Lennox-Gastaut with External Trigeminal Nerve Stimulation LOS ANGELES, Jan. 6, 2015 /PRNewswire/ -- NeuroSigma®, Inc.
HOUSTON, Jan. 5, 2015 /PRNewswire/ -- Cyberonics, Inc.
Double-Blind Controlled Clinical Trial Opens Enrollment at the UCLA Semel Institute LOS ANGELES, Jan. 5, 2015 /PRNewswire/ -- NeuroSigma®, Inc.
Multi-disciplinary Tuberous Sclerosis Complex Center to provide greateraccess and quality of care to TSC patients throughout the Midwest. Chicago, IL (PRWEB)
HOUSTON, Dec. 22, 2014 /PRNewswire/ -- Cyberonics, Inc.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.